What is the clinical significance of the COL1A1 variant rs751268781 (RCV000387770) and its association with arthrochalasia‑type Ehlers‑Danlos syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Significance of COL1A1 Variant rs751268781 (RCV000387770)

This specific COL1A1 variant is associated with arthrochalasia-type Ehlers-Danlos syndrome (aEDS), a rare autosomal recessive form when homozygous, presenting with severe joint hypermobility, congenital bilateral hip dislocation, skin hyperextensibility, and muscle hypotonia.

Genetic and Inheritance Pattern

The variant in question corresponds to c.2050G>A, p.(Glu684Lys) in COL1A1, which has been identified as a recurrent founder mutation in Saudi Arabian populations 1. Unlike typical aEDS (which is autosomal dominant from splice-site variants causing exon 6 skipping), this specific missense variant causes disease only in the homozygous state, making it autosomal recessive 2, 1.

Key Genetic Features:

  • Heterozygous carriers are asymptomatic 1
  • Homozygous individuals develop arthrochalasia-like EDS phenotype
  • Located in exon 31 of COL1A1, affecting the triple helical domain 2
  • Represents a founder mutation with multiple families sharing identical variant 1

Clinical Phenotype and Severity

The homozygous p.(Glu684Lys) variant produces an intermediate severity phenotype between severe neonatal forms (with respiratory distress and recurrent fractures) and classical EDS 2.

Cardinal Clinical Features:

  • Severe congenital hypotonia (often initially mistaken for neuromuscular disorders)
  • Bilateral congenital hip dislocation (present in most aEDS cases) 3
  • Generalized joint hypermobility with recurrent subluxations
  • Skin hyperextensibility
  • Craniofacial dysmorphism
  • Muscle hypotonia requiring early intervention 2

Important Clinical Pitfall:

This presentation can initially mimic neuromuscular disorders due to prominent hypotonia, delaying correct diagnosis 2. Always consider collagenopathies in the differential diagnosis of congenital hypotonia, particularly when accompanied by joint hypermobility or hip dislocation.

Morbidity and Long-Term Outcomes

Based on aEDS cohort data, significant morbidity includes 3:

  • Orthopedic complications: Hip surgery required in ~40% of patients; spinal surgery in ~25%
  • Mobility impairment: Approximately 33% become wheelchair-bound or unable to walk unaided
  • Fractures: Present in 75% of individuals, with rare cases requiring bisphosphonate treatment
  • Quality of life: Despite severity, majority of adults can enter careers with appropriate support

Genotype-Phenotype Correlation:

Individuals with COL1A1 variants (including this missense variant) tend to be more severely affected in musculoskeletal features compared to COL1A2 variants 3.

Management Approach

Since no curative treatment exists, management focuses on symptomatic treatment and quality of life optimization 4:

Immediate Neonatal/Infant Period:

  • Orthopedic evaluation for hip dislocation (surgical correction often needed)
  • Physical therapy for hypotonia
  • Monitoring for respiratory complications

Ongoing Multidisciplinary Care:

  • Orthopedic surveillance: Regular monitoring for joint instability, scoliosis development
  • Physical therapy: Strengthening exercises, joint protection strategies
  • Pain management: Chronic pain is common
  • Cardiac screening: Echocardiography to exclude structural abnormalities (though cardiac involvement less common in aEDS than vascular EDS) 3

Critical Surveillance Point:

Unlike hypermobile EDS, COL1A1-related disorders can have vascular fragility 5. While not the dominant feature in this specific variant, awareness is essential for surgical planning and trauma management.

Reproductive Counseling

For families with this variant:

  • 25% recurrence risk for each pregnancy when both parents are heterozygous carriers
  • Prenatal testing available via targeted sequencing
  • One reported case of affected mother delivering two affected children with preterm labor but no major obstetric complications 3

Diagnostic Confirmation

Whole-exome sequencing followed by confirmatory Sanger sequencing is the standard approach 2. Both parents should be tested to confirm carrier status and establish recessive inheritance pattern.


The "uncertain" risk status likely reflects the rarity of this variant and limited published cases, but the evidence clearly establishes pathogenicity when homozygous, with a well-defined arthrochalasia-like EDS phenotype requiring comprehensive orthopedic and supportive management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.